Discover 785 paid clinical trials in Louisiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Louisiana offers numerous opportunities to explore paid clinical studies for both healthy volunteers and those with specific health concerns. Leading research centers in New Orleans, Baton Rouge, and Shreveport are currently seeking participants, offering access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 785
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for
IgA Nephropathy
Location: Boston MA, New Haven CT, New York NY, Clifton Park NY,
Sponsor: Calliditas Therapeutics AB
Sex: All
Age: 18+
Code: NCT06712407
Recruiting
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
for
Breast Neoplasms
Location: Baton Rouge LA
Sponsor: Pennington Biomedical Research Center
Sex: Female
Age: 18+
Code: NCT06318507
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
for
Chondral Defect, Osteochondritis Dissecans (OCD),
Location: Philadelphia PA, Baltimore MD, Akron OH, Columbus OH,
Sponsor: Vericel Corporation
Sex: All
Age: 10 - 17
Code: NCT03588975
Phase3, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
for
Chronic Diabetic Foot Ulcers
Location: New York NY, York PA, Pembroke Pines FL, Ford City PA,
Sponsor: SerenaGroup, Inc.
Sex: All
Age: 18+
Code: NCT04457752
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, Worcester MA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Stony Brook NY, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome
for
NAS
Location: New Hyde Park NY, Valhalla NY, New York NY,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 0+
Code: NCT03533985
Recruiting
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
for
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7,
Sponsor: Academic and Community Cancer Research United
Sex: Female
Age: 18+
Code: NCT04197687
Phase2, Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,